Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor
Authors:
Open Access
- 17 January 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 9 (4) , 531-542
Abstract
Attempts to expand ex vivo the numbers of human hematopoietic stem cells (HSCs) without compromising their marrow repopulating capacity and their ability to establish multilineage hematopoiesis has been the subject of intense investigation. Although most such efforts have focused on cord blood HSCs, few have been applied to adult HSCs, a more clinically relevant HSC source for gene modification. To date, the strategies that have been used to expand adult HSCs have resulted in modest effects or HSCs with lineage bias and a limited ability to generate T cells in vivo. We previously reported that culturing umbilical cord blood CD34+ cells in serum-free media supplemented with valproic acid (VPA), a histone deacetylase inhibitor, and a combination of cytokines led to the expansion of the numbers of fully functional HSCs. In the present study, we used this same approach to expand the numbers of adult human CD34+ cells isolated from mobilized peripheral blood and bone marrow. This approach resulted in a significant increase in the numbers of phenotypically defined HSCs (CD34+CD45RA-CD90+D49f+). Cells incubated with VPA also exhibited increased aldehyde dehydrogenase activity and decreased mitochondrial membrane potential, each functional markers of HSCs. Grafts harvested from VPA-treated cultures were able to engraft in immune-deficient mice and, importantly, to generate cellular progeny belonging to each hematopoietic lineage in similar proportion to that observed with unmanipulated CD34+ cells. These data support the utility of VPA-mediated ex vivo HSC expansion for gene modification of adult HSCs. Significance statement This study shows that the transplantation of ex vivo valproic acid (VPA)-treated, adult mobilized peripheral blood and bone marrow hematopoietic stem cells (HSCs) into immune-deficient mice led to nonbiased long-term multilineage hematopoietic cell engraftment including T cells. These data support the use of VPA-mediated ex vivo HSC expansion for future gene modification strategies.Keywords
This publication has 38 references indexed in Scilit:
- Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell functionHaematologica, 2013
- Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem CellsScience, 2010
- Valproic Acid Increases CXCR4 Expression in Hematopoietic Stem/Progenitor Cells by Chromatin RemodelingStem Cells and Development, 2009
- Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cuesExperimental Hematology, 2009
- Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell, 2007
- Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potentialBlood, 2006
- Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplantsBone Marrow Transplantation, 2005
- Histone Deacetylase Inhibitor Valproic Acid Enhances the Cytokine-Induced Expansion of Human Hematopoietic Stem CellsCancer Research, 2005
- Modification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin ABlood, 2004
- Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansionExperimental Hematology, 2001